Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study

MS Treatments

Jahr

Publikationsjahr
2021

Autoren

Autorenliste der Publikation
Wundes A, Wray S, Gold R, Singer BA, Jasinska E, Ziemssen T, de Seze J, Repovic P, Chen H, Hanna J, Messer J, Miller C, Naismith RT.

Verlag

Publisher-Information
Ther Adv Neurol Disord. 2021 Mar 19;14:1756286421993999

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/1756286421993999

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2021